Hillstream BioPharma Inc. Made Big Gain

Hillstream BioPharma Inc. (HILS:NASDAQ) rocketted at $3.13, a gain of 21.8%. On Wed, Jan 19, 2022, HILS:NASDAQ touched a New 2-Week Intraday High of $2.86. The stock got featured on our News Catalysts scanner on Sat, Jan 15, 2022 at 12:27 AM in the 'PUBLIC OFFERING' category. From Thu, Jan 13, 2022, the stock recorded 33.33% Up Days and 25.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About Hillstream BioPharma Inc. (HILS:NASDAQ)
Hillstream BioPharma Inc is a biotechnology company developing novel therapeutic candidates targeting ferroptosis, an emerging new anti-cancer mechanism resulting in iron mediated cell death for drug...
Top 10 Gainers:
- Aptorum Group Limited (APM:NASDAQ), 38.52%
- Hillstream BioPharma Inc. (HILS:NASDAQ), 21.79%
- AMTD International Inc. (HKIB:NYSE), 16.63%
- Adagio Therapeutics Inc. (ADGI:NASDAQ), 16.04%
- Amesite Inc. (AMST:NASDAQ), 15.93%
- Pintec Technology Holdings Limited (PT:NASDAQ), 15.19%
- Bragg Gaming Group Inc. (BRAG:NASDAQ), 14.65%
- Society Pass Incorporated (SOPA:NASDAQ), 12.45%
- HCW Biologics Inc. (HCWB:NASDAQ), 12.08%
- OncoCyte Corporation (OCX:NASDAQ), 12.05%